| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.611 | 6.176 | 8.086 | 2.214 | 502 | 0 | 0 | 0 | 0 | 14.953 |
| Total Income - EUR | 5.611 | 6.176 | 8.086 | 2.214 | 502 | 0 | 0 | 466 | 0 | 15.028 |
| Total Expenses - EUR | 2.753 | 3.035 | 5.236 | 1.176 | 150 | 12 | 12 | 383 | 167 | 4.846 |
| Gross Profit/Loss - EUR | 2.858 | 3.142 | 2.850 | 1.038 | 352 | -12 | -12 | 83 | -167 | 10.182 |
| Net Profit/Loss - EUR | 2.315 | 3.142 | 2.350 | 972 | 337 | -12 | -12 | 69 | -167 | 8.576 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Aphorme Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 388 | 384 | 378 | 371 | 364 | 357 | 349 | 0 | 0 | 671 |
| Current Assets | 1.325 | 2.517 | 2.151 | 2.415 | 1.441 | 1.414 | 573 | 1.734 | 1.562 | 9.509 |
| Inventories | 105 | 327 | 102 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.144 | 1.683 | 1.589 | 2.344 | 1.366 | 1.353 | 526 | 1.313 | 1.309 | 1.555 |
| Cash | 76 | 507 | 460 | 71 | 74 | 61 | 47 | 421 | 253 | 7.954 |
| Shareholders Funds | -25.392 | -21.454 | -18.740 | -17.425 | -16.751 | -16.445 | -16.093 | -16.073 | -16.192 | -7.525 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 27.159 | 24.429 | 21.284 | 20.225 | 18.569 | 18.230 | 17.028 | 17.808 | 17.754 | 17.706 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Aphorme Srl